Kerl H - Search Results

1

Common polymorphisms in the interleukin-22 gene are not associated with chronic plaque psoriasis.

Weger W, Hofer A, Wolf P, El-Shabrawi Y, Renner W, Kerl H, Salmhofer W. Weger W, et al. Among authors: kerl h. Exp Dermatol. 2009 Sep;18(9):796-8. doi: 10.1111/j.1600-0625.2009.00840.x. Epub 2009 Mar 27. Exp Dermatol. 2009. PMID: 19469905

2

The angiotensin-converting enzyme insertion/deletion and the endothelin -134 3A/4A gene polymorphisms in patients with chronic plaque psoriasis.

Weger W, Hofer A, Wolf P, El-Shabrawi Y, Renner W, Kerl H, Salmhofer W. Weger W, et al. Among authors: kerl h. Exp Dermatol. 2007 Dec;16(12):993-8. doi: 10.1111/j.1600-0625.2007.00620.x. Exp Dermatol. 2007. PMID: 18031458

3

The methylenetetrahydrofolate reductase 677C>T gene polymorphism is not associated with chronic plaque psoriasis.

Weger W, Hofer A, Stanger O, Wolf P, El-Shabrawi Y, Renner W, Kerl H, Salmhofer W. Weger W, et al. Among authors: kerl h. Exp Dermatol. 2008 Sep;17(9):748-51. doi: 10.1111/j.1600-0625.2008.00713.x. Epub 2008 Mar 18. Exp Dermatol. 2008. PMID: 18355300

4

Role of the interleukin 15 96516A>T and IL15 96330C>A gene polymorphisms in Caucasian patients with chronic plaque psoriasis.

Weger W, Hofer A, Wolf P, El-Shabrawi Y, Renner W, Kerl H, Salmhofer W. Weger W, et al. Among authors: kerl h. J Dermatol Sci. 2008 Aug;51(2):147-9. doi: 10.1016/j.jdermsci.2008.02.010. J Dermatol Sci. 2008. PMID: 18424079 No abstract available.

5

Narrowband UV-B phototherapy, alefacept, and clearance of psoriasis.

Legat FJ, Hofer A, Wackernagel A, Salmhofer W, Quehenberger F, Kerl H, Wolf P. Legat FJ, et al. Among authors: kerl h. Arch Dermatol. 2007 Aug;143(8):1016-22. doi: 10.1001/archderm.143.8.1016. Arch Dermatol. 2007. PMID: 17709660 Clinical Trial.

6

Comparison of phototherapy with near vs. far erythemogenic doses of narrow-band ultraviolet B in patients with psoriasis.

Hofer A, Fink-Puches R, Kerl H, Wolf P. Hofer A, et al. Among authors: kerl h. Br J Dermatol. 1998 Jan;138(1):96-100. doi: 10.1046/j.1365-2133.1998.02032.x. Br J Dermatol. 1998. PMID: 9536229 Clinical Trial.

7

Treatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept.

Wolf P, Hofer A, Legat FJ, Bretterklieber A, Weger W, Salmhofer W, Kerl H. Wolf P, et al. Among authors: kerl h. Br J Dermatol. 2009 Jan;160(1):186-9. doi: 10.1111/j.1365-2133.2008.08926.x. Epub 2008 Nov 25. Br J Dermatol. 2009. PMID: 19067710

8

High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.

Kreimer-Erlacher H, Seidl H, Bäck B, Cerroni L, Kerl H, Wolf P. Kreimer-Erlacher H, et al. Among authors: kerl h. J Invest Dermatol. 2003 Apr;120(4):676-82. doi: 10.1046/j.1523-1747.2003.12085.x. J Invest Dermatol. 2003. PMID: 12648234 Free article.

9

Reduction of treatment frequency and UVA dose does not substantially compromise the antipsoriatic effect of oral psoralen-UVA.

Legat FJ, Hofer A, Quehenberger F, Kahofer P, Kerl H, Wolf P. Legat FJ, et al. Among authors: kerl h. J Am Acad Dermatol. 2004 Nov;51(5):746-54. doi: 10.1016/j.jaad.2004.04.029. J Am Acad Dermatol. 2004. PMID: 15523353 Clinical Trial.

10

Lack of oncogenic mutations in the c-Met catalytic tyrosine kinase domain in acral lentiginous melanoma.

Seidl H, Weger W, Wolf P, Kerl H, Schaider H. Seidl H, et al. Among authors: kerl h. Int J Dermatol. 2008 Dec;47(12):1327-9. doi: 10.1111/j.1365-4632.2008.03818.x. Int J Dermatol. 2008. PMID: 19126036 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

555 results

Search Page

Filters